Orphenadrine
Anti-muscarinic analogue agent similar to Diphenhydramine with no sedative effect. Used for the treatment of muscle spasms and Parkinson Disease.
At latest update, relevant published data on excretion into breast milk were not found.
Its pharmacokinetics (moderately high molecular weight and high protein-binding capacity) makes excretion into breast milk in significant amount be unlikely.
Until more data on this medication is available, safer alternative drugs are preferred especially in premature babies or during the neonatal period.
Whenever used while breastfeeding take the lowest dose as possible along with a follow-up for somnolence and troubles of the infant with feeding.
It is not commercially available in Spain.
Alternatives
- Baclofen (Very Low Risk)
- Methocarbamol (Low Risk probable)
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- Mephenamine Citrate
- Orphenadrine Citrate
Writings
- Орфенадрина Цитрат (Cyrillic)
- オルフェナドリンクエン酸塩 (Japanese)
Drug trade names
References
- eMC. Orphenadrine. Drug Summary. 2013 Full text (in our servers)
- Rosemont Pharmaceuticals Ltd. Orphenadrine. Drug Summary. 2013 Full text (in our servers)
- Farmical. Orfenadrina. Ficha técnica. 2010 Full text (in our servers)
- Lee SY, Oh HJ, Kim JW, Kim YG, Moon CJ, Lee EH. Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2006Abstract
- Labout JJ, Thijssen Ct, Keijser GG, Hespe W. Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man. Eur J Clin Pharmacol. 1982Abstract